University of Pittsburgh logo

Publications

2026

Cell Cycle Regulation of Merkel Cell Polyomavirus Replication and Genome Inheritance in Single Cells.  Smeal SW, Zhou H, Hasib M, Abere B, Kowalczyk GJ, Schipper D, Huang Y, Yufei Huang, Moore PS, Chang Y, Lee REC, BioRXiv. 2026 Aug 3: doi: https://doi.org/10.64898/2026.07.31.741607 Epub ahead of print. [Abstract] 

Increasing Intrinsic Protein Disorder Improves CD8+ Immunogenicity for a SARS CoV2 Vaccine Candidate Antigen. Wan L, Xie B, Shuda M, O'Malley ME, Camacho CJ, Delgoffe GM, Chang Y, Moore PS. Mol Ther. 2026 Jun 15:S1525-0016(26)00504-6. doi: 10.1016/j.ymthe.2026.06.027. Epub ahead of print. PMID: 42298822. [Full Text] | [PubMed]

2025

Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition. Collura JL, Lei KC, Chandra M, Kervarrec T, Park HJ, Dalkoohi M, Becker JC, Chang Y, Moore PS, Shuda M. Proc Natl Acad Sci USA. 2025 Dec 30;122(52):e2516667122. doi: 10.1073/pnas.2516667122. Epub 2025 Dec 24. PMID: 41439710; PMCID: PMC12772197. [Full Text] | [PubMed]

Primary Sequence-Intrinsic Immune Evasion by Viral Proteins Guides CTL-Based Vaccine Strategies. Wan L, Shuda M, Chang Y, Moore PS. Viruses. 2025 Jul 24;17(8):1035. doi: 10.3390/v17081035. PMID: 40872750; PMCID: PMC12390343. [Full Text] | [PubMed]

2024

Engineered protein destabilization reverses intrinsic immune evasion for candidate vaccine pan-strain KSHV and SARS-CoV-2 antigens. Wan L, Xie B, Shuda M, Delgoffe G, Chang Y, Moore PS. bioRxiv. 2024 Oct 22:2024.10.22.619692. doi: 10.1101/2024.10.22.619692. [Full Text] | [PubMed]

Are There More Human Cancer Viruses Left to Be Found? Moore PS, Chang Y.  Annu Rev Virol. 2024 Sep;11(1):239-259. doi: 10.1146/annurev-virology-111821-103721.PMID: 39326883 [Full Text] | [PubMed]

2023

Membrane-bound Merkel cell polyomavirus middle T protein constitutively activates PLCg1 signaling through Src-family kinases. Peng W-Y, Abere B, Shi H, Toland S, Smithgall TE, Moore PS, Chang Y. Proc Natl Acad Sci USA. 2023 Dec 19;120(51):e2316467120. doi: 10.1073/pnas.2316467120.  [Full Text] | [PubMed]

Unlicensed origin DNA melting by MCV and SV40 polyomavirus LT proteins is independent of ATP-dependent helicase activity. Wan L, Toland S, Robinson-McCarthy LR, Lee N, Schaich MA, Hengel SR, Li X, Bernstein KA, Van Houten B, Chang Y, Moore PS.  Proc Natl Acad Sci USA. 2023 July 17; 120 (30) e2308010120. doi: 10.1073/pnas.2308010120.
[Full Text] | [PubMed]

Mitotic CDK1 and 4E-BP1 I: Loss of 4E-BP1 serine 82 phosphorylation promotes proliferative polycystic disease and lymphoma in aged or sublethally irradiated mice. Sun R, Guo S, Shuda Y, Chakka AB, Rigatti LH, Zhao G, Ali MAE, Park CY, Chandran U, Yu J, Bakkenist CJ, Shuda M , Moore PS, Chang Y. PLOS ONE. 2023 May 5;18(5): e0282722. doi: 10.1371/journal.pone.0282722.
[Full Text] | [PubMed]

Mitotic CDK1 and 4E-BP1 II: A single phosphomimetic mutation in 4E-BP1 induces glucose intolerance in mice. Cao S, Jurczak MJ, Shuda Y, Sun R, Shuda M, Chang Y, Moore PS. PLOS ONE. 2023 Mar 10;18(3): e0282914. doi: 10.1371/journal.pone.0282914.
[Full Text] | [PubMed]

Development and Characterization of a New Monoclonal Antibody against SARS-CoV-2 NSP12 (RdRp). Meng W, Guo S, Cao S, Shuda M, Robinson-McCarthy LR, McCarthy KR, Shuda Y, Paniz-Mondolfi AE, Bryce C, Grimes Z, Sordillo EM, Cordon-Cardo C, Li P, Zhang H, Perlman S, Guo H, Gao SJ, Chang Y, Moore PS. J Med Virol. 2023 Jan; 95(1): e28246. doi: 10.1002/jmv.28246. 
[Full Text] | [PubMed]

2022

KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine. Casper C, Corey L, Cohen JI, Damania B, Gershon AA, Kaslow DC, Krug LT, Martin J, Mbulaiteye SM, Mocarski ES, Moore PS, Ogembo JG, Phipps W, Whitby D, Wood C.  npj Vaccines. 2022 Sept 20; 7:108. doi: 10.1038/s41541-022-00535-4.
[Full Text] | [PubMed]

Replication Kinetics for a Reporter Merkel Cell Polyomavirus. Abere B, Zhou H, Shuda M, Stolz DB, Rapchak K, Moore PS, Chang Y. Viruses. 2022 Feb 25;14(3), 473. doi: 10.3390/v14030473. 
[Full Text] | [PubMed]

Construction and characterization of two SARS-CoV-2 minigenome replicon systems. Zhang H, Fischer DK, Shuda M, Moore PS, Gao SJ, Ambrose Z, Guo H. J Med Virol. 2022 Jun;94(6):2438-2452. Doi: 10.1002/jmv.27650. PMID: 35137972. Epub 2022 Feb 19.      
[Full Text] | [PubMed]

2021

SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems. Zhang F, Li W, Feng J, Ramos da Silva S, Ju E, Zhang H, Chang Y, Moore PS, Guo H, Gao SJ.  J Med Virol. 2021 Dec;93(12):6671-6685. doi: 10.1002/jmv.27244. PMID: 34324210. Epub 2021 Aug 4.
[Full Text] | [PubMed]

2020

Merkel Cell Polyomavirus Encodes Circular RNAs (circRNAs) Enabling a Dynamic circRNA/microRNA/mRNA Regulatory Network. Abere B, Zhou H, Li J, Cao S, Toptan T, Grundhoff A, Fischer N, Moore PS, Chang Y.  mBio. 2020 Dec 15;11(6). doi:10.1128/mBio.03059-20. 
[Full Text] | [PubMed]

Proteomic approach to discover human cancer viruses from formalin-fixed tissues. Toptan T, Cantrell PS, Zeng X, Liu Y, Sun M, Yates NA, Chang Y, Moore PS.  JCI Insight. 2020 Nov 19;5(22). doi:10.1172/jci.insight.143003.
[Full Text] | [PubMed]

Sirolimus and other mTOR inhibitors directly activate latent pathogenic human polyomavirus replication. Alvarez Orellana J, Kwun HJ, Artusi S, Chang Y, Moore PS.  J Infect Disease. 2020 Feb 15;pii: jiaa071. doi: 10.1093/infdis/jiaa071.
 
Kaposi’s sarcoma-associated herpesvirus-encoded circRNAs are expressed in infected tumor tissues and are incorporated into virions. Abere B, Li J, Zhou H, Toptan T, Moore PS, Chang Y.   mBio. 2020 Jan 7;11(1). pii: e03027-19. doi: 10.1128/mBio.03027-19.
[Full Text] | [PubMed]

2019

Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E). Sun R, Cheng E, Velásquez C, Chang Y, Moore PS.  J Biol Chem. 2019 Aug 2;294:11840-11852. doi: 1074/jbc.RA119.008512. 
[Full Text] | [PubMed] 

Widespread keratosis pilaris-like eruption in an immunocompromised child. Frigerio A, Toptan T, Chang Y, Abbott J, Cipriano SD, Bowen AR. JAAD Case Rep. 2019 Apr 5;5(4):352-354. doi: 10.1016/j.jdcr.2019.02.001.
[Full Text] | [PubMed]

2018

Limited detection of human polyomaviruses in Fanconi anemia related squamous cell carcinoma. Toptan T, Brusadelli MG, Turpin B, Witte DP, Surrallés J, Velleuer E, Schramm M, Dietrich R, Brakenhoff RH, Moore PS, Chang Y, Wells S.  PLOS One.2018 Dec 27;13(12):e0209235.
[Full Text] | [PubMed] 
 
Characterization of a Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Cell Line CVG-1. Velásquez C, Amako Y, Harold A, Toptan T, Chang Y, Shuda M.  Front Microbiol. 2018 Apr 11;9:713. doi: 10.3389/fmicb.2018.00713. eCollection 2018. PMID: 29696010.
[Full Text] | [PubMed] 

Circular DNA tumor viruses make circular RNAs. Toptan T, Abere B, Nalesnik MA, Swerdlow SH, Ranganathan S, Lee N, Shair KH, Moore PS, and Chang Y.  Proc Natl Acad Sci USA. 2018. doi: 10.1073/pnas.1811728115. Epub 2018 August 27.
[Full Text] | [PubMed]

2017

Theme issue ‘Human Oncogenic Viruses’ compiled and edited by Yuan Chang, Patrick S. Moore and Robin A. Weiss, Philos Trans R Soc Lond B Biol Sci 372 (1732). 2017 Sep 11.
[Full Text] | [PubMed]
 
Merkel Cell Polyomavirus small T Antigen Induces Genome Instability by E3 Ubiquitin Ligase Targeting. Kwun HJ, Wendzicki JA, Moore PS, Chang Y.  Oncogene. 2017.
[Full Text] | [PubMed]
 
Protein-mediated viral latency is a novel mechanism for Merkel cell polyomavirus persistence. Kwun HJ, Chang Y, Moore PS.  Proc Natl Acad Sci USA. 2017. May 16;114(20):E4040-E4047. doi: 10.1073/pnas.1703879114. Epub 2017 May 1.
[Full Text] | [PubMed]
 
Common Commensal Cancer Viruses. Moore PS, Chang Y (2017) PLoS Pathog 13(1): e1006078. doi: 10.1371/journal.ppat.1006078.
[Full Text] | [PubMed]

2016

Rat Polyomavirus 2 (RatPyV2): Identification and Characterization of a Novel Polyomavirus in a Colony of X-SCID Rats. Toptan T, Rigatti L, Newsome J, Moore PS, and Chang Y.  mSphere 00334-16R1. 2016.  
[Full Text] | [PubMed]
 
Mitotic protein kinase CDK1 phosphorylation of mRNA translation regulator 4E-BP1 Ser83 may contribute to cell transformation. Velasquez C, Cheng E, Shuda M, Lee-Oesterreich PJ, Pogge von Strandmann L, Gritsenko MA, Jacobs JM, Moore PS, Chang Y. Proc Natl Acad Sci USA. 2016 Jul 26;113(30):8466-71. doi: 10.1073/pnas.1607768113. Epub 2016 Jul 11.
[Full Text] | [PubMed]
 
Survey for human polyomaviruses in cancer. Toptan T, Yousem SA, Ho J, Matsushima Y, Stabile LP, Fernandez-Figueras MT, Bhargava R, Ryo A, Moore PS, Chang Y. JCI Insight. 2016;1(2):e85562. doi:10.1172/jci.insight.85562.
[Full Text] | [PubMed]

2015

Merkel Cell Polyomavirus Small T Antigen Induces Cancer and Embryonic Merkel Cell Proliferation in a Transgenic Mouse Model. Shuda M, Guastafierro A, Geng X, Shuda Y, Ostrowski SM, Lukianov S, Jenkins FJ, Honda K, Maricich SM, Moore PS, Chang Y.  PLoS One 2015 Nov 6;10(11):e0142329.
[Full Text] | [PubMed]
 
Merkel Cell Polyomavirus T Antigens Promote Cell Proliferation and Inflammatory Cytokine Gene Expression. Richards K, Guastafierro A, Shuda M, Toptan T, Moore PS, Chang Y.  J Gen Virol. 2015 Sep 17. doi: 10.1099/jgv.0.000287.
[Full Text] | [PubMed]
 
Human Polyomavirus 7-associated Pruritic Rash and Viremia in Transplant Recipients. Ho J, Jedrych JJ, Feng H, Natalie AA, Grandinetti L, Mirvish E, Crespo MM, Yadav D, Fasanella KE, Proskell S, Kuan SF, Pastrana DV, Buck CB, Shuda Y, Moore PS, Chang Y.  J Infect Dis. 2015 May 15;211(10):1560-5.
[Full Text] | [PubMed]
 
CDK1 substitutes for mTOR Kinase to activate mitotic cap-dependent protein translation. Shuda M, Velasquez C, Cheng E, Cordek DG, Kwun HJ, Chang Y, Moore PS.  Proc Natl Acad Sci USA. 2015 Apr 16. pii: 201505787.
[Full Text] | [PubMed]
 
Large T and small T antigens of Merkel cell polyomavirus. Wendzicki JA, Moore PS, Chang Y.  Curr Opin Virol. 2015 Feb 11;11C:38-43. doi: 10.1016/j.coviro.2015.01.009.
[Full Text] | [PubMed]
 
Restricted Protein Phosphatase 2A Targeting by Merkel Cell Polyomavirus Small T Antigen. Kwun HJ, Shuda M, Camacho CJ, Gamper AM, Thant M, Chang Y, Moore PS.  J Virol. 2015 Apr 15;89(8):4191-200. doi: 10.1128/JVI.00157-15.
[Full Text] | [PubMed] 

2014

Human DNA Tumor Viruses Generate Alternative Reading Frame Proteins Through Repeat Sequence Coding. Kwun HJ, Toptan T, Ramos da Silva S, Atkins JF, Moore PS, Chang Y.  Proc Nat Acad Sci USA. 2014. 
[Full Text] | [PubMed]
 
Merkel Cell Polyomavirus Positive Merkel Cell Carcinoma Requires Viral Small T Antigen for Cell Proliferation. Shuda M, Chang Y, Moore PS.  J Invest Dermatol. 2014 May;134(5):1479-81.
[Full Text] | [PubMed]
 
Twenty years of KSHV. Chang Y, Moore P. Viruses. 2014 Nov 7;6(11):4258-64. doi: 10.3390/v6114258.
[Full Text] | [Pubmed]
 
Human Polyomavirus 7-associated Pruritic Rash and Viremia in Transplant Recipients. Ho J, Jedrych JJ, Feng H, Natalie AA, Grandinetti L, Mirvish E, Crespo MM, Yadav D, Fasanella KE, Proskell S, Kuan SF, Pastrana DV, Buck CB, Shuda Y, Moore PS, Chang Y. J Infect Dis. 2014.
[Full Text] | [PubMed]
 
The Vps39-like TRAP1 is an effector of Rab5 and likely the missing Vps3 subunit of human CORVET. Lachmann J, Glaubke E, Moore PS, Ungermann C.  Cell Logist. 2014 Oct 2;4(4):e970840.
[Full Text] | [PubMed]
 
Kaposi’s Sarcoma-Associated Herpesvirus: General Features. Toptan T, Moore PS, Chang Y.  Reference Module in Biomedical Sciences. 2014.
[Full Text] 

2013

Response of Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Xenografts to a Survivin Inhibitor. Dresang LR, Guastafierro A, Arora R, Normolle D, Chang Y, Moore PS.  PLoS ONE. 2013 Nov 18;8(11):e80543. doi: 10.1371/journal.pone.0080543. eCollection 2013.
[Full Text] | [PubMed]
 
The T Antigen locus of Merkel Cell Polyomavirus Down-regulates Human Toll-like Receptor 9 Expression. Shahzad N, Shuda M, Gheit T, Kwun HJ, Cornet I, Saidj D, Zannetti C, Hasan U, Chang Y, Moore PS, Accardi R, Tommasino M. J Virol. 2013; 87(23):13009-19.
[Full Text] | [PubMed]
 
Merkel Cell Polyomavirus Small T Antigen Controls Viral Replication and Oncoprotein Expression by Targeting the Cellular Ubiquitin Ligase SCFFbw7. Kwun HJ, Shuda M, Feng H, Camacho CJ, Moore PS, Chang Y.  Cell Host and Microbe. 2013; 14(2):125-135. 
[Full Text] | [PubMed]
 
Merkel Cell Polyomavirus and Non-Small Cell Lung Cancer. Shuda M, Feng H, Moore PS, Chang Y.  Br J Cancer. 2013; 123(6):2964-702.
[Full Text] | [PubMed]
 
Multicolor microRNA fish effectively differentiates tumor types. Renwick N, Cekan P, Masry PA, McGeary SE, Miller JB, Hafner M, Li Z, Mihailovic A, Morozov P, Brown M, Gogakos T, Mobin MB, Snorrason EL, Feilotter HE, Zhang X, Perlis CS, Wu H, Suarez-Farinas M, Feng H, Shuda M, Moore PS, Tron VA, Chang Y, Tuschl T.  J Clin Invest 2013; Jun 3;123(6):2694-702.
[Full Text] | [PubMed]
 
Complex Alternative Cytoplasmic Protein Isoforms of the Kaposi’s Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Generated through Noncanonical Translation Initiation. Toptan T, Fonseca L, Kwun HJ, Chang Y, Moore PS.  J Virol. 2013 Mar. 
[Full Text] | [PubMed]
 
Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells. Forero A, Moore PS, Sarkar SN.  J Immunol. 2013 Aug 1;191(3):1476-85. doi: 10.4049/jimmunol.1202514. Epub 2013 Jun 26.
[Full Text] | [PubMed]

2012

Characterization of an early passage Merkel cell Polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice. Guastafierro A, Feng H, Thant M, Kirkwood JM, Chang Y, Moore PS, Shuda M. J Virol Methods 2012;187(1):6-14.
[Full Text] | [PubMed]
 
Survivin is a therapeutic target in merkel cell carcinoma. Arora R, Shuda M, Guastafierro A, Feng H, Toptan T, Tolstov Y, Normolle D, Vollmer LL, Vogt A, Domling A, Brodsky JL, Chang Y, Moore PS.  Sci Transl Med. 2012 May 9;4(133):133ra56. 
[Full Text] | [PubMed]
 
Extensive terminal and asymmetric processing of small RNAs from rRNAs, snoRNAs, snRNAs, and tRNAs. Li Z, Ender C, Meister G, Moore PS, Chang Y, John B.  Nucleic Acids Res. 2012 Apr 9.
[Full Text] | [PubMed]
 
Lack of integrin 5 in Merkel cell carcinomas and derived cell lines is frequently associated with Merkel cell polyomavirus. Akgül B, Zigrino P, Hufbauer M, Liu X, Moore PS, Mauch C, Pfister H.  J Dermatol Sci. 2012 Jul;67(1):66-8. doi: 10.1016/j.jdermsci.2012.03.006. Epub 2012 Mar 30.
[Full Text] | [PubMed]
 
MCV and Merkel cell carcinoma: a molecular success story. Arora R, Chang Y, Moore PS.  Curr Opin Virol. 2012 Aug;2(4):489-98. doi: 10.1016/j.coviro.2012.05.007. Epub 2012 Jun 17.2012 Jun 17. 
[Full Text] | [PubMed]

2011

Merkel cell carcinoma: a virus-induced human cancer. Chang Y, Moore PS. Annu Rev Pathol. 2012;7:123-44. doi: 10.1146/annurev-pathol-011110-130227. Epub 2011 Sep 13.
[PubMed]
 
Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes. Dresang LR, Teuton JR, Feng H, Jacobs JM, Camp II DG, Purvine SO, Gritsenko MA, Li Z, Smith RD, Sudgden B, Moore PS, Chang Y.  BMC Genomics 2011; 12(1):625.
[Full Text] | [PubMed]
 
Merkel Cell Polyomavirus Small T Antigen Is a PP2A-independent Human Oncoprotein Targeting the Translation Regulator 4E-BP1. Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS.  J Clin Invest, 2011 doi:10.1172/JCI46323. 
[Full Text] | [PubMed]
 
Cellular and viral factors regulating Merkel cell polyomavirus replication. Feng H, Kwun HJ, Liu X, Gjoerup O, Stolz DB, Chang Y, Moore PS.  PLoS One, 2011 6(7): e22468.
[Full Text] | [PubMed]
 
Asymptomatic primary Merkel cell polyomavirus infection among adults. Tolstov YL, Knauer A, Chen JG, Kensler TW, Kingsley LA, Moore PS, Chang Y.  Emerg Infect Dis. 2011 17(8). 
[Full Text] | [PubMed]
 
Merkel cell polyomavirus large T antigen disrupts lysosome clustering by translocating human VAM6P to the nucleus. Liu X, Hein J, Richardson SC, Basse PH, Moore PS, Gjoerup O, Chang Y. J Biol Chem, 2011 May 13;286(19):17079-90. 
[Full Text] | [PubMed]
 
KSHV: forgotten but not gone. Moore PS, Chang Y.  Blood, 2011 117(26): 6973-6974. 
[Full Text] | [PubMed]
 
 Asymmetric assembly of Merkel cell polyomavirus large T-antigen origin binding domains at the viral origin. Harrison CJ, Meinke G, Kwun HJ, Rogalin H, Phelan P, Bullock P, Chang Y, Moore PS, Bohm A. J Mol Bio, 2011 409(4): 529-542.
[Full Text] | [PubMed]
 
The central repeat domain 1 of Kaposi’s sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation. Kwun HJ, Ramos da Silva S, Qin H, Ferris RL, Tan R, Chang Y, Moore PS. Virology, 2011 Apr 10;412(2):357-65.
[Full Text] | [PubMed]
 
Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. Schrama D, Peitsch WK, Zapatka M, Kneitz H, Houben R, Eib S, Haferkamp S, Moore PS, Shuda M, Thompson JF, Trefzer U, Pföhler C, Scolyer RA, Becker JC.  J Invest Dermatol. 2011 Aug;131(8):1631-8. doi: 10.1038/jid.2011.115. Epub 2011 May 12.
[Full Text] | [PubMed]

2010

 Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma. Reisinger DM, Shiffer JD, Cognetta Jr. AB, Chang Y, and Moore PS. J Am Acad Dermatol. 2010 63(3):400-403. 
 
 Merkel cell polyomavirus infected Merkel cell carcinoma cells require expression of viral T antigens. Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, Moore PS, Becker JC. J Virol. 2010 84:7064-7072.
 
Lack of evidence for direct involvement of Merkel cell polyomavirus (MCV) in chronic lymphocytic leukemia (CLL). Tolstov YL, Arora R, Scudiere SC, Busam K, Chaudhary PM, Chang Y, Moore PS. Blood. 2010 115(23): 4973-4. 
[Full Text] | [PubMed]
 
A sensitive nonradioactive northern blot method to detect small RNAs. Kim S, Li Z, Moore PS, Monaghan A, Chang Y, Nichols M, John B.  Nuc Acids Research, 2010 Apr 1;38(7):e98. Epub 2010 Jan 15. 
[Full Text] | [PubMed]
 
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Moore PS, Chang Y. Nat Rev Cancer, 2010 Dec. 10(12): 878-889.
[Full Text] | [PubMed]
 
Merkel Cell Carcinoma: Incidence, Mortality, and Risk of Other Cancers. Kaae J, Hansen AV, Biggar RJ, Boyed HA, Moore PS, Wohlfahrt J, Melbye M.  J Natl Cancer Inst. 2010 102(11): 793-801. 
[Full Text] | [PubMed]
 
Update on human polyomaviruses and cancer. Gjoerup O, Chang Y.  Adv Cancer Res.2010 106:1-51.
[Full Text] | [PubMed]

2009

The minimum replication origin of Merkel cell polyomavirus has a unique large T antigen loading architecture and requires small T antigen expression for optimal replication. Kwun HJ, Guastafierro A, Shuda M, Meinke G, Bohm A, Moore PS, Chang Y.  J Virol 2009; 83(23):12118-28.
[Full Text] | [PubMed]
 
Characterization of viral and human RNAs smaller than canonical microRNAs. Li Z, Kim SW, Lin Y, Moore P S, Chang Y, John B. J Virol, 2009 Dec;83(24):12751-58.
[Full Text] | [PubMed]
 
Quantitation of human seroresponsiveness to Merkel cell polyomavirus. Pastrana DV, Tolstov YL, Becker JC, Moore PS, Chang Y, Buck CB.  PLoS Pathog, 2009 Sept;5(9):e1000578. 
 
Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Tolstov Y, Pastrana D, Feng H, Becker J, Jenkins F, Moschos S, Chang Y, Buck C, Moore PS. Int J Cancer, 2009 125:1250-1256. 
[Full Text] | [PubMed]
 
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernandez-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH, Chaudhary PM, Kirkwood JM, Nalesnik MA, Kant JA, Weiss LM, Moore PS, Chang Y.  Int J Cancer. 2009 125:1243-9. 
[Full Text] | [PubMed]
 
Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Busam K, Jungbluth AA, Rekhtman N, Coit D, Pulitzer M, Bini JM, Arora R, Hanson NC, Tassello JA, Frosina D, Moore PS, Chang Y. Am J Surg Path, 2009 Sep;33(9):1378-85. 
[Full Text] | [PubMed]
 
Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus; role of viral FLICE inhibitory protein K13-induced NF-kappaB activation. Punj V, Matta H, Schamus S, Yang T, Chang Y, Chaudhary PM. Blood, 2009 113(22):5660-8. 
[Full Text] | [PubMed]
 
Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Shuda M, Moore PS. DISSENT: Lombardi VC et al. Science. 2009 Oct 23; 326-585-9. Faculty of 1000. 2010. 
 
Merkel Cell Polyomavirus: The Seventh Human Cancer Virus? Moschos S, Chang Y, and Moore PS. The Melanoma Letter, 2009 Summer; 27(2). 
[Full Text]

2008

T-antigen mutations are a tumor-specific signature for Merkel cell polyomavirus. Shuda M, Feng H, Kwun H, Rosen ST, Gjoerup O, Moore PS, Chang Y. Proc Natl Acad Sci, USA. 2008 21;105(42):16272-7. 
[Full Text] | [PubMed]
 
Clonal Integration of a Polyomavirus in Merkel Cell Carcinoma. Feng H, Shuda M, Chang Y, Moore PS. Science. 2008 319(5866): 1096-1100. 
[Full Text] | [PubMed]  

2007

Durable remission of HIV-negative, Kaposi’s sarcoma herpes virus-associated multicentric Castleman disease in patients with rheumatoid arthritis treated with methotrexate. Jacobs SA, Vidnovic N, Patel H, Soma LA, Chang Y, Bass N, Swerdlow SH. Clin Rheumatol. 2007; 26(7):1148-50.
[Full Text] | [PubMed]
 
 Human Transcriptome subtraction using short sequence tags to search for tumor viruses in conjunctival carcinoma. Feng H, Taylor JL, Benos PV, Newton R, Waddell K, Lucas SB, Chang Y, and Moore PS.J Virol. 2007 Oct:81 (20):11332-40.
[Full Text] | [PubMed]
 
Transmission of human herpesvirus 8 by blood transfusion. Moore PS, Chang Y, Jaffe H.  N Engl J Med. 2007; 356:88. 
[PubMed]
 
Kaposi’s sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. Kwun HJ, da Silva SR, Shah IM, Blake N, Moore PS, Chang Y. J Virol. 2007 Aug;81(15):8225-35. Epub 2007 May 23.
[Full Text] | [PubMed]

2006

Use of a Multiantigen Detection Algorithm for Diagnosis of Kaposi’s Sarcoma-Associated Herpesvirus Infection. Laney AS, Peters J, Manzi S, Kingsley L, Chang Y, Moore PS. J Clin Micro. 2006 Oct;44(10):3734-41. 
[Full Text] | [PubMed]

2005

Kaposi sarcoma-associated herpesvirus and primary and secondary pulmonary hypertension. Laney AS, De Marco T, Peters JS, Malloy M, Teehankee C, Moore PS, Chang Y. Chest. 2005; 127(3):762-7.
[Full Text] | [PubMed]
 
Intrabodies targeting the Kaposi’s sarcoma-associated herpesvirus latency antigen inhibit viral persistence. Corte-Real S, Collins C, Aires da Silva F, Simas JP, Barbas C, Chang Y, Moore P, Goncalves J. Blood. 2005; 106(12):3797-802.
[Full Text] | [PubMed]
 
Transcriptional analysis of the latent and inducible KSHV transcripts in the K4-K7 region. Taylor JL, Bennett HN, Snyder BA, Moore PS, and Chang Y. J Virol. 2005; 79(24):15099-106. 

2004

Seroprevalence of Kaposi’s sarcoma-associated herpesvirus in various populations in Cuba. Kourí V, Eng SM, Rodríguez ME, Resik S, Orraca O, Moore PS, Chang Y. Rev Panam Salud Publica. 2004 May;15(5):320-5.
[Full Text] | [PubMed]

2003

Kaposi’s Sarcoma-Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin? Moore PS, Chang Y. Ann Rev Microbiol. 2003; 57:609-39. 
[Full Text] | [PubMed]
 
The latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication. Fejér G, Medveczky MM, Horvath E, Lane B, Chang Y, Medveczky PG. J Gen Virol. 2003 Jun;84(Pt 6):1451-62.
[Full Text] | [PubMed]

2002

Viral IL-6-Induced Cell Proliferation and Immune Evasion of Interferon Activity. Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS. Science. 2002; 298:1432-5. 

2001

A novel etiology of renal allograft dysfunction. Markowitz GS, Williams GS, Chang Y, Hardy MA, Saouaf R, D’Agati VD.  Am J Kidney Dis. 2001 Sep;38(3):658-63.
[Full Text] | [PubMed]
 
Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelopeglycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding. Navenot JM, Wang ZX, Trent JO, Murray JL, Hu QX, DeLeeuw L, Moore PS, Chang Y, Peiper SC. J Mol Biol. 2001 Nov 9;313(5):1181-93.
[Full Text] | [PubMed]
 
Kaposi’ sarcoma-associated herpesvirus: A new DNA tumor virus. Boshoff C, Chang Y. Annu Rev Med. 2001; 52:453-470.
[Full Text] | [PubMed]
 
Molecular virology of Kaposi’s sarcoma-associated herpesvirus. Moore PS, Chang Y. Philos Trans R Soc Lond B Biol Sci. 2001; 356:499-516.
[Full Text] | [PubMed]
 
Kaposi’s sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. Rivas C, Thlick AE, Parravicini C, Moore PS, Chang Y. J Virol. 2001; 75:429-3.
[Full Text] | [PubMed]

2000

Kaposi’s sarcoma. Antman K, Chang Y. N Engl J Med. 2000; 342:1027-38.
[Full Text] | [PubMed]
 
Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi’s sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay. Olsen SJ, Sarid R, Chang Y, Moore PS. J Infect Dis. 2000; 182:306-10.
[Full Text] | [PubMed]
 
Differential viral protein expression in Kaposi’s sarcoma-associated herpesvirus-infected diseases: Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. Parravicini C, Chandran B, Corbellino M, Berti E, Paulli M, Moore PS, Chang Y. Am J Pathol. 2000; 156:743-9.
[Full Text] | [PubMed]
 
KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Stine JT, Wood C, Hill M, Epp A, Raport CJ, Schweickart VL, Endo Y, Sasaki T, Simmons G, Boshoff C, Clapham P, Chang Y, Moore P, Gray PW, Changry D. Blood. 2000; 95:1151-7.
[Full Text] | [PubMed]
 
Seroprevalence of Kaposi’s Sarcoma-Associated Herpesvirus in Healthy Adults in Israel. Iscovich J, Fischbein A, Fisher-Fischbein J, Freedman LS, Eng SM, Boffetta P, Vudovich A, Glasman C, Goldschmidt R, Livingston M, Heger-Maslansky B, Brennan P, Moore PS. Anticancer Res 20 (3B), 2119-2122. May-Jun 2000.
[Europe PMC]

1999

Involvement of IL-10 and viral IL-6 in the spontaneous growth of Kaposi’s sarcoma herpesvirus-infected body cavity lymphoma cells. Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G. Blood.1999; 94(8):2871-79. 
[Full Text] | [PubMed]
 
KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Osborne J, Moore PS, Chang Y. Hum Immunol. 1999 Oct;60(10):921-7.
[Full Text] | [PubMed]
 
Posttransplantation plasmacytic proliferations related to Kaposi’s sarcoma-associated herpesvirus. Matsushima AY, Strauchen JA, Lee G, Scigliano E, Hale EE, Weisse MT, Burstein D, Kamel O, Moore PS, Chang Y. Am J Surg Pathol. 1999 Nov;23(11):1393-400.
[PubMed]
 
Kaposi’s sarcoma-associated herpesvirus and multiple myeloma: lack of criteria for causality. Tarte K, Chang Y, Klein B. Blood. 1999 May 15;93(10):3159-63; discussion 3163-4.
[Full Text] | [PubMed]
 
Angiogenesis and hematopoiesis induced by Kaposi’s sarcoma-associated herpesvirus-encoded interleukin-6. Aoki Y, Jaffe ES, Chang Y, Jones K, Teruya-Feldstein J, Moore PS, Tosato, G. Blood. 1999;93(12):4034-43.
[Full Text] | [PubMed]
 
Characterization and cell cycle regulation of the major Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. Sarid R, Wiezorek JS, Moore PS, Chang Y. J Virol. 1999; 73:1438-46.
[Full Text] | [PubMed]
 
Kaposi’s sarcoma-associated herpesvirus: a new human tumor virus, but how? Schulz TF, Moore PS. Trends Microbiol. 1999;7(5):196-200. 
[Full Text] | [PubMed]
 
Kaposi’s sarcoma-associated herpesvirus: a sexually transmissible infection? Grulich AE, Olsen SJ, Luo K, Hendry O, Cunningham P, Cooper DA, Gao SJ, Chang Y, Moore PS, Kaldor JM.  J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):387-93.
[PubMed]

1998

Kaposi’s sarcoma-associated herpesvirus is not detected with immunosuppression in multiple myeloma. Tarte K, Olsen SJ, Rossi JF, Legouffe E, Lu ZY, Jourdan M, Chang Y, Klein B.  Blood. 1998 Sep 15;92(6):2186-8.  
[Full Text] | [PubMed]
 
Increasing Kaposi’s sarcoma–associated herpesvirus seroprevalence with age in a highly Kaposi’s sarcoma endemic region, Zambia in 1985. Olsen SJ, Chang Y, Moore PS, Biggar RJ, Melbye M. AIDS. 1998 Oct 1;12(14):1921-5.
[Full Text] | [PubMed]
 
Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) arising in dura. Kambham N, Chang Y, Matsushima AY. Clin Neuropathol. 1998 Nov-Dec;17(6):311-7.
[PubMed]
 
Clinical-grade functional dendritic cells from patients with multiple myeloma are not infected with Kaposi’s sarcoma-associated herpesvirus. Tarte K, Olsen SJ, Yang Lu Z, Legouffe E, Rossi JF, Chang Y, Klein B. Blood. 1998 Mar 15;91(6):1852-7.
[Full Text] | [PubMed]
 
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Boshoff C, Gao SJ, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, Moore PS, Weiss RA, Chang Y. Blood. 1998 Mar 1;91(5):1671-9.
[Full Text] | [PubMed]
 
Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV. Moore PS, Chang Y. Trends Genetics. 1998;14(4):144-50. 
[Full Text] | [PubMed]
 
Evidence against KSHV infection in the pathogenesis of multiple myeloma. Olsen SJ, Tarte K, Sherman W, Hale EE, Weisse MT, Orazi A, Klein B, Chang Y. Virus Res. 1998; 57:197-202.
[Full Text] | [PubMed]
 
Human herpesvirus 8 variants (or KSHV and Water buffalos). Moore, PS. Lancet. 1998; 351:Feb. 28 issue. 
[Full Text] | [PubMed]
 
Transcriptional mapping of the Kaposi’s sarcoma-associated herpesvirus (KSHV) genome in the body cavity-based lymphoma cell line BC-1. Sarid R, Flore O. Bohenzky RA, Chang Y. Moore PS. J. Virol. 1998: 72:1005-12.
[Full Text] | [PubMed]
 
First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations. Sanders EJ, Marfin AA, Tukei PM, Kuria G, Ademba G, Agata NN, Ouma JO, Cropp CB, Karabatsos N, Reiter P, Moore PS, Gubler DJ. Am J Trop Med Hyg. 1998 Oct;59(4):644-9.
[Full Text] | [PubMed]

1997

KSHV ORF K9 (vIRF) is an oncogene that inhibits the interferon signaling pathway. Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. Oncogene. 1997; 15:1979-86.
[Full Text] | [PubMed]
 
Angiogenic and HIV inhibitory functions of KSHV-encoded chemokines. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani M, Sasaki T, Williams TJ, Gray PW, Moore PS, Chang Y, Weiss RA. Science. 1997; 278:290-4.
[Full Text] | [PubMed]
 
Delayed posthypoxic demyelination. Association with arylsulfatase A deficiency and lacticacidosis on proton MR spectroscopy. Gottfried JA, Mayer SA, Shungu DC, Chang Y, Duyn JH. Neurology. 1997 Nov;49(5):1400-4.
[Full Text] | [PubMed]
 
Kaposi’s sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Sarid R, Sato T, Bohenzky RA, Russo JJ, Chang Y. Nature Med. 1997; 3:293-8.
[Full Text] | [PubMed]
 
Unusual intramedullary vascular lesion: report of two cases. Schwartz TH, Chang Y, Stein BM. Neurosurgery. 1997 Jun;40(6):1295-301.
[Full Text] | [PubMed]
 
The cyclin encoded by Kaposi’s sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA, Mittnacht S. J Virol. 1997 Jun;71(6):4193-8.
[Full Text] | [PubMed]
 
Selective switch between latency and lytic replication of Kaposi’s sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y. J Virol. 1997 Jan;71(1):314-24.
[Full Text] | [PubMed]
 
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman’s disease. Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y. Am J Pathol. 1997 Dec;151(6):1517-22.
[Full Text] | [PubMed]
 
A Kaposi’s sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. Journal of Biological Chemistry. 1997; 272:19625-31.
[Full Text] | [PubMed]
 
The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF. J Virol. 1997; 71:5915-21. 
[Full Text] | [PubMed]
 
Risk of Kaposi’s sarcoma-associated herpesvirus transmission from donor allografts among Italian posttransplant Kaposi’s sarcoma patients. Parravicini C, Olsen SJ, Capra M, Poli F, Sirchia G, Gao SJ, Berti E, Nocera A, Rossi E, Bestetti G, Pizzuto M, Galli M, Moroni M, Moore PS, Corbellino M. Blood. 1997; 90:2826-9.
[Full Text] | [PubMed]

1996

Kaposi’s Sarcoma (KS)-associated herpesvirus and its role in KS. Chang Y, Moore PS. Infect Agents Dis. 1996 Oct;5(4):215-22.
[PubMed]
 
Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma. Strauchen JA, Hauser AD, Burstein D, Jimenez R, Moore PS, Chang Y. Ann Intern Med. 1996 Nov 15;125(10):822-5.
[Full Text] | [PubMed]
 
Kaposi’s sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi’s sarcoma and malignant lymphoma. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, Knowles DM. J Virol. 1996 Nov;70(11):8218-23.
 
Antibodies to butyrate inducible antigens of Kaposi’s sarcoma-associated herpesvirus in HIV-1 infected patients. Miller G, Rigsby MO, Heston L, Grogan E, Sun R, Metroka C, Levy JA, Gao SJ, Chang Y, Moore PS. New Eng J Med. 1996; 334:1292-7.
[Full Text] | [PubMed]
 
Seroconversion to antibodies against Kaposi’s sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi’s sarcoma. Gao SJ, Kingsley L, Hoover D, Spira T, Rinaldo C, Saah A, Phair J, Detels R, Parry P, Chang Y, Moore PS. New Eng J Med. 1996; 335:233-41. 
[Full Text] | [PubMed]
 
Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Gaidano G, Cechova K, Chang Y, Moore PS, Knowles DM, Dalla-Favera R. Leukemia. 1996 Jul;10(7):1237-40.
[PubMed]
 
Kaposi’s sarcoma-associated herpesvirus and Kaposi’s sarcoma in Africa. Uganda Kaposi’s Sarcoma Study Group. Chang Y, Ziegler J, Wabinga H, Katangole-Mbidde E, Boshoff C, Schulz T, Whitby D, Maddalena D, Jaffe HW, Weiss RA, Moore PS. Arch Intern Med. 1996 Jan 22;156(2):202-4.
[Full Text] | [PubMed]
 
Kaposi’s sarcoma-associated herpesvirus infection prior to onset of Kaposi’s sarcoma. Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, Parry JP, Conley LJ, Jaffe HW, Chang Y. AIDS. 1996 Feb;10(2):175-80.
[PubMed]
 
Cyclin encoded by KS herpesvirus. Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, Godden-Kent, Paterson H, Weiss RA, Mittnacht S. Nature. 1996; 382:410.
[Full Text] | [PubMed]
 
Primary characterization of a herpesvirus agent associated with Kaposi’s sarcoma [published erratum appears in J. Virol 1996 70(12): 9083]. PS Moore, Gao SJ, Dominguez G, Cesarman E, Lungu O, Knowles DM, Garber R, Pellett PE, McGeoch DJ and Chang Y. J Virol. 1996; 70: 549-58. 
[Full Text] | [PubMed]
 
Prevalence of Kaposi’s sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS. Lancet. 1996; 348:1133-8.
[Full Text] | [PubMed]
 
Molecular mimicry of human cytokine and cytokine-response pathway genes by KSHV. Moore PS, Boshoff C, Weiss RA, Chang Y. Science. 1996; 274:1739-44.
[PubMed]
 
Nucleotide sequence of Kaposi’s sarcoma-associated herpesvirus (HHV8). Russo JJ, Bohenzky RA, Chien M, Chen K, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. Proc Natl Acad Sci, USA. 1996; 93:148627.
[Full Text] | [PubMed] 
 
Molecular approaches to the identification of unculturable infectious agents. Gao SJ, Moore PS. Emerging Infect Dis. 1996; 2:159-67. 
[Full Text] | [PubMed]
 
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Gao SJ, Kingsley L, Li M, Zhang W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS. Nature Medicine. 1996; 2:925-28. 
[Full Text] | [PubMed]
 
HHV8 and skin cancers in immunosuppressed patients. Boshoff C, Talbot S, Kennedy M, O’Leary J, Schulz T, Chang Y. Lancet. 1996 Jul 13;348(9020):138.

1995

Detection of herpesvirus-like DNA sequences in Kaposi’s sarcoma from persons with and without HIV infection. Moore PS and Chang Y. New Eng J Med. 1995; 332:1181-85.  
[Full Text] | [PubMed]
 
Kaposi’s sarcoma-associated herpesvirus-like DNA sequences are detectable in AIDS-related body cavity based non-Hodgkin’s lymphomas. Cesarman E, Chang Y, Moore PS, Said J, Knowles DM. New Eng J Med, 1995; 332:1186-91.
[Full Text] | [PubMed]
 
In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi’s sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. Blood. Oct 1995; 86: 2708 – 2714.
[Full Text] | [PubMed]
 
Risk factors for adverse outcome in persons with pneumococcal pneumonia. Marfin AA, Sporrer J, Moore PS, Siefkin AD. Chest. 1995 Feb;107(2):457-62.
[Full Text] | [PubMed]

1994

 Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS.Science. 1994; 265:1865-69.
[Full Text] | [PubMed]
 
Cytokines in the central nervous system: expression of macrophage colony stimulating factor and its receptor during development. Chang Y, Albright S, Lee F. J Neuroimmunol. 1994 Jun;52(1):9-17.
[PubMed]
 
Infectious disease surveillance during emergency relief to Bhutanese refugees in Nepal. Marfin AA, Moore J, Collins C, Biellik R, Kattel U, Toole MJ, Moore PS. JAMA. 1994 Aug 3;272(5):377-81.
[Full Text] | [PubMed]

1993

Role of nutritional status and weight loss in HIV seroconversion among Rwandan women.  Moore PS, Allen S, Sowell AL, Van de Perre P, Huff DL, Serufilira A, Nsengumuremyi F, Hulley SB. J Acquir Immune Defic Syndr 1993; 6(6):611-616.
[Full Text] | [PubMed]
 
Epidemiologic aspects of a St. Louis encephalitis epidemic in Jefferson County Arkansas, 1991. Marfin AA, Bleed DM, Lofgren JP, Olin AC, Savage HM, Smith GC, Moore PS, Karabatsos N, Tsai TF. Am J Trop Med Hyg 1993; 49(1):30-37.
 
Detection of meningitis epidemics in Africa: a population-based analysis. Moore PS, Plikaytis BD, Bolan GA, Oxtoby MJ, Yada A, Zoubga A, Reingold AL, Broome CV. Int J Epidemiol. 1992; 21(1):155-162.
[Full Text] | [PubMed]
 
Inherited syndrome of infantile olivopontocerebellar atrophy, micronodular cirrhosis, and renal tubular microcysts: review of the literature and a report of an additional case. Chang Y, Twiss JL, Horoupian DS, Caldwell SA, Johnston KM. Acta Neuropathol. 1993;86(4):399-404.
[Full Text] | [PubMed]
 
Localized hypertrophic mononeuropathy of the trigeminal nerve. Chang Y, Horoupian DS, Jordan J, Steinberg G. Arch Pathol Lab Med. 1993 Feb;117(2):170-6.
[PubMed]
 
Intraventricular and subarachnoid hemorrhage resulting from necrotizing vasculitis of the choroid plexus in a patient with Churg-Strauss syndrome. Chang Y, Kargas SA, Goates JJ, Horoupian DS. Clin Neuropathol. 1993 Mar-Apr;12(2):84-7.
[PubMed]
 
Outbreak of Japanese encephalitis on the island of Saipan, 1990. Paul WS, Moore PS, Karabatsos N, Flood SP, Yamada S, Jackson T, Tsai TF. J Infect Dis. 1993 May;167(5):1053-8.
[Full Text] | [PubMed]
 
Mortality rates in displaced and resident populations of central Somalia during 1992 famine. Moore PS, Marfin AA, Quenemoen LE, Gessner BD, Ayub YS, Miller DS, Sullivan KM, Toole MJ. Lancet. 1993 Apr 10;341(8850):935-8.
[PubMed]
 
Public Health Service Surveillance of the health status of Butanese refugees – Nepal, 1992. MMWR .1193:14-17.
 
Public Health Service Arboviral diseases – United States, 1992. MMWR. 1993; 42:467-468.

1992

A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. Achtman M, Kusecek B, Morelli G, Eickmann K, Wang JF, Crowe B, Wall RA, Hassan-King M, Moore PS, Zollinger W. J Infect Dis. 1992; 165(1):53-68.
[Full Text] | [PubMed]
 
Detection of meningitis epidemics in Africa: a population-based analysis. Moore PS, Plikaytis BD, Bolan GA, Oxtoby MJ, Yada A, Zoubga A, Reingold AL, Broome CV. Int J Epidemiol. 1992 Feb;21(1):155-62.
[PubMed]
 
Cranial hypertrophic interstitial neuropathy. Jordan JE, Lane B, Marks M, Chang Y, Weinberger M. AJNR Am J Neuroradiol. 1992 Nov-Dec;13(6):1552-4.
[Full Text] | [PubMed]
 
Public Health Service Arboviral encephalitis: United States, 1991. MMWR. 1992; 41:545-548.
 
Public Health Service Population-based mortality assessment-Baidoa and Afgoi, Somalia, 1992. MMWR 1992; 41:913:917.

1991

Inflammatory pseudotumor of the choroid plexus in Sjögren’s disease. Chang Y, Horoupian DS, Lane B, Fross RD, Smyth LT Jr, Seiling RJ. Neurosurgery. 1991 Aug;29(2):287-90.
[PubMed]
 
L-tryptophan and the eosinophilia-myalgia syndrome: pathologic findings in eight patients. Herrick MK, Chang Y, Horoupian DS, Lombard CM, Adornato BT. Hum Pathol. 1991 Jan;22(1):12-21.
[PubMed]
 
Helicobacter pylori infection in intestinal– and diffuse-type gastric adenocarcinomas. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. J Natl Cancer Inst. 1991 May 1;83(9):640-3.
[PubMed]
 
Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989. Gillespie SM, Chang Y, Lemp G, Arthur R, Buchbinder S, Steimle A, Baumgartner J, Rando T, Neal D, Rutherford G, et al. Ann Neurol. 1991 Oct;30(4):597-604.
[Full Text] | [PubMed]
 
Helicobacter pylori infection and the risk of gastric carcinoma. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. N Engl J Med. 1991 Oct 17;325(16):1127-31.
[Full Text] | [PubMed]
 
Public Health Service St. Louis encephalitis outbreak-Arkansas. MMWR. 1991; 40:605-607.
 
Borrelia burgdorferi: survival in experimentally infected human blood processed for transfusion. Johnson SE, Swaminathan B, Moore P, Broome CV, Parvin M. J Infect Dis. 1990 Aug;162(2):557-9.
[Full Text] | [PubMed]

1990

Evolution of post-natal herpes simplex virus encephalitis to multicystic encephalopathy. Chang Y, Soffer D, Horoupian DS, Weiss LM. Acta Neuropathol. 1990;80(6):666-70.
[Full Text] | [PubMed]
 
Primary cutaneous rhabdomyosarcoma. Chang Y, Dehner LP, Egbert B. Am J Surg Pathol. 1990 Oct;14(10):977-82.
[Full Text] | [PubMed]
 
Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. Moore PS, Hierholzer J, DeWitt W, Gouan K, Djoré D, Lippeveld T, Plikaytis B, Broome CV. JAMA. 1990 Sep 12;264(10):1271-5.
[Full Text] | [PubMed]

1989

National surveillance of Lyme disease, 1987-1988. Tsai TF, Bailey RE, Moore PS. Conn Med. 1989 Jun;53(6):324-6.
[PubMed]
 
Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Moore PS, Reeves MW, Schwartz B, Gellin BG, Broome CV. Lancet. 1989 Jul 29;2(8657):260-3.
[PubMed]
 
Human immunodeficiency virus (HIV) seroprevalence in persons attending STD clinics in the United States, 1985-1987. Cannon RO, Schmid GP, Moore PS, Pappaioanou M. Sex Transm Dis. 1989 Oct-Dec;16(4):184-9.
[PubMed]

1988

Smooth muscle cells can express cytokeratins of “simple” epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. Gown AM, Boyd HC, Chang Y, Ferguson M, Reichler B, Tippens D. Am J Pathol. 1988 Aug;132(2):223-32.
[Full Text] | [PubMed]
 
Public Health Service Human Immunodeficiency virus infection in the United States; A review of current knowledge. MMWR. 1988; 36(Supplement):1-48.
 
Group A meningococcal carriage in travelers returning from Saudi Arabia. Moore PS, Harrison LH, Telzak EE, Ajello GW, Broome CV. JAMA. 1988 Nov 11;260(18):2686-9.
[Full Text] | [PubMed]

1979

Antagonism between high pressure and anesthetics in the thermal phase-transition of dipalmitoylphosphatidylcholine bilayer. Kamaya H, Ueda I, Moore PS, Eyring H. Biochim Biophys Acta. 1979 Jan 5;550(1):131-7.
[Full Text] | [PubMed]